Search results
Neonatal jaundice. Treatment threshold graphs. NICE clinical guideline 98. Developed by the National Collaborating Centre for Women’s and Children’s Health. These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool.
What's new? Highlights the challenge of identifying G6PD deficiency in infants. Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.
5 sie 2022 · The 2004 guideline made recommendations for primary prevention (eg, maternal Rh typing and treatment) and secondary prevention (eg, risk- factor assessment and close monitoring for the development of hyperbilirubinemia, and, when necessary, treatment).
Neonatal Algorithm for Bilirubinometer use. Transcutaneous Bilirubin Measurement (TcB) Measures bilirubin of subcutaneous tissue and closely correlates with serum bilirubin. Measurement site: Sternum or forehead. Clinically Jaundiced. Do Not Use TCB. *Previous/current Phototherapy use <35 weeks <24 hours. > days. Please do SBR.
One of the most common conditions requiring medical attention in newborn babies. Occurs in approximately 60% of term and 80% of preterm babies in the first week of life. 3.6% of all babies born in Queensland (2020) had phototherapy.
12 cze 2023 · Neonatal hyperbilirubinemia is the most commonly encountered clinical issue in newborn babies. A number of risk factors contribute to severe hyperbilirubinemia in newborn infants with gestational age ≥ 35 weeks.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
